Holding(s) in Company
TR-1(i): NOTIFICATION OF MAJOR INTERESTS IN SHARES
1. Identity of the issuer or the underlying issuer of existing shares to which voting rights are attached (ii):
System C Healthcare Plc
2. Reason for the notification (please state Yes/No):
An acquisition or disposal of voting rights: (Yes)
An acquisition or disposal of qualifying financial instruments which may result in the acquisition of shares already issued to which voting rights are attached: (No)
An acquisition or disposal of instruments with similar economic effect to qualifying financial instruments: (No)
An event changing the breakdown of voting rights: (No)
Other (please specify): (No)
3. Full name of person(s) subject to the notification obligation (iii):
Gartmore Investment Limited
4. Full name of shareholder(s) (if different from 3.) (iv):
Gartmore Fund Managers Ltd A/c Gartmore UK & Irish Smaller Companies
Strathclyde Pension Fund
The Alphagen Volantis Fund Limited
5. Date of the transaction and date on which the threshold is crossed or reached (v):
22/02/11
6. Date on which issuer notified:
23/02/11
7. Threshold(s) that is/are crossed or reached:
5%
8. Notified details:
A: Voting rights attached to shares (viii), (ix)
|
Class/type of shares if possible using the ISIN CODE |
Situation previous to the triggering transaction |
|
|
|
Number of shares |
Number of voting Rights |
|
GB00B0940H91 Ordinary shares 10p |
6,119,102 |
6,119,102 |
|
Resulting situation after the triggering transaction |
|||||
|
Class/type of shares if possible using the ISIN CODE |
Number of shares |
Number of voting rights (ix) |
% of voting rights (x) |
||
|
|
Direct |
Direct (xi) |
Indirect (xii) |
Direct |
Indirect |
|
GB00B0940H91 Ordinary shares 10p |
5,779,102 |
|
5,779,102 |
|
4.965% |
B: Qualifying Financial Instruments
|
Resulting situation after the triggering transaction |
||||
|
Type of financial instrument |
Expiration date (xiii) |
Exercise/Conversion Period (xiv) |
Number of voting rights that may be acquired if the instrument is exercised/ converted |
% of voting rights |
|
|
|
|
|
|
C: Financial Instruments with similar economic effect to Qualifying Financial Instruments(xv), (xvi)
|
Resulting situation after the triggering transaction |
||||||
|
Type of financial |
Exercise price |
Expiration date (xvii) |
Exercise/ |
Number of voting rights instrument refers to |
% of voting rights (xix), (xx)
|
|
|
|
|
|
|
|
Nominal |
Delta |
|
|
|
|||||
Total (A+B+C)
|
Number of voting rights |
% of voting rights |
|
5,779,102 |
4.965% |
9. Chain of controlled undertakings through which the voting rights and/or the financial instruments are effectively held, if applicable (xxi):
N/A
Proxy Voting:
10. Name of the proxy holder:
N/A
11. Number of voting rights proxy holder will cease to hold:
N/A
12. Date on which proxy holder will cease to hold voting rights:
N/A
13. Additional information:
All figures are based on the Company's issued share capital of 116,394,316 as provided by Exshare
Email contact RDU@Gartmore.com
14. Contact name:
RDU
15. Contact telephone number:
020 7782 2324
This information is provided by RNS